{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T21:58:59Z","timestamp":1785362339164,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008048","name":"Nanjing University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["T2222013"],"award-info":[{"award-number":["T2222013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52073203"],"award-info":[{"award-number":["52073203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52233008"],"award-info":[{"award-number":["52233008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.biomaterials.2026.124333","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T15:40:15Z","timestamp":1779550815000},"page":"124333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dual-functional poly(disulfide) enables \u201cOnce-and-for-all\u201d atherosclerosis therapy via precision hepatocyte base editing"],"prefix":"10.1016","volume":"335","author":[{"given":"Xiaoping","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8890-2508","authenticated-orcid":false,"given":"Shijuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minzan","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9628-296X","authenticated-orcid":false,"given":"Qing-Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9489-4241","authenticated-orcid":false,"given":"Ruibing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2026.124333_bib1","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/eurheartj\/ehaf289","article-title":"Acute coronary syndromes: mechanisms, challenges, and new opportunities","volume":"46","author":"Kraler","year":"2025","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biomaterials.2026.124333_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.117312","article-title":"Non-HDL-cholesterol in dyslipidemia: review of the state-of-the-art literature and outlook","volume":"383","author":"Raja","year":"2023","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biomaterials.2026.124333_bib3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41569-024-01039-5","article-title":"The LDL cumulative exposure hypothesis: evidence and practical applications","volume":"21","author":"Ference","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biomaterials.2026.124333_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13457","article-title":"Liver-specific ATP-Citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis","volume":"7","author":"Pinkosky","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124333_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/medsci13030137","article-title":"Effect of Spirulina platensis versus simvastatin on the Skeletal Muscles of experimentally induced dyslipidemia: a multitarget approach to muscle ultrastructural and cytomolecular modulation","volume":"13","author":"Abdelhady","year":"2025","journal-title":"Med. Sci."},{"key":"10.1016\/j.biomaterials.2026.124333_bib6","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.3390\/jcm12062444","article-title":"Management of statin intolerant patients in the era of novel lipid lowering therapies: a critical approach in clinical practice","volume":"12","author":"Bosco","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biomaterials.2026.124333_bib7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrcardio.2018.3","article-title":"Advances in lipid-lowering therapy through gene-silencing technologies","volume":"15","author":"Nordestgaard","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biomaterials.2026.124333_bib8","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41569-023-00860-8","article-title":"Novel and future lipid-modulating therapies for the prevention of cardiovascular disease","volume":"20","author":"Brandts","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biomaterials.2026.124333_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108480","article-title":"Targeting PCSK9 to tackle cardiovascular disease","volume":"249","author":"Hummelgaard","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biomaterials.2026.124333_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.tcm.2023.01.008","article-title":"ANGPTL3 inhibition, dyslipidemia, and cardiovascular diseases","volume":"34","author":"Luo","year":"2024","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.biomaterials.2026.124333_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7555\/JBR.32.20170114","article-title":"Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia","volume":"33","author":"Tarugi","year":"2019","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.biomaterials.2026.124333_bib12","article-title":"CRISPR\/Cas9 delivery mediated with hydroxyl-rich nanosystems for gene editing in aorta","volume":"6","author":"Zhang","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2026.124333_bib13","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1038\/s41467-023-37465-1","article-title":"GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy","volume":"14","author":"Kasiewicz","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124333_bib14","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1021\/acscentsci.0c01648","article-title":"Rational design of poly(disulfide)s as a universal platform for delivery of CRISPR-Cas9 machineries toward therapeutic genome editing","volume":"7","author":"Guo","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.biomaterials.2026.124333_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41551-019-0357-8","article-title":"Adenine base editing in an adult mouse model of tyrosinaemia","volume":"4","author":"Song","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biomaterials.2026.124333_bib16","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41587-021-00933-4","article-title":"In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels","volume":"39","author":"Rothgangl","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2026.124333_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of lipid nanoparticles for RNA delivery","volume":"55","author":"Eygeris","year":"2022","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biomaterials.2026.124333_bib18","doi-asserted-by":"crossref","first-page":"12181","DOI":"10.1021\/acs.chemrev.1c00244","article-title":"Lipids and lipid derivatives for RNA delivery","volume":"121","author":"Zhang","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biomaterials.2026.124333_bib19","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2026.124333_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202307190","article-title":"Controllable star cationic poly(Disulfide)s achieve genetically Cascade catalytic therapy by delivering bifunctional fusion plasmids","volume":"35","author":"Yu","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124333_bib21","doi-asserted-by":"crossref","first-page":"12153","DOI":"10.1021\/jacs.5b08130","article-title":"Intracellular delivery of functional proteins and native drugs by cell-penetrating poly(disulfide)s","volume":"137","author":"Fu","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2026.124333_bib22","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1002\/anie.201813665","article-title":"Self-assembled and size-controllable oligonucleotide nanospheres for effective antisense gene delivery through an endocytosis-independent pathway","volume":"58","author":"Zhou","year":"2019","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.biomaterials.2026.124333_bib23","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41565-018-0171-6","article-title":"Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular Corona","volume":"13","author":"Tonigold","year":"2018","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2026.124333_bib24","doi-asserted-by":"crossref","first-page":"8267","DOI":"10.1021\/acsnano.0c08596","article-title":"Caveolae-mediated endocytosis drives robust siRNA delivery of polymeric nanoparticles to macrophages","volume":"15","author":"Song","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124333_bib25","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa2404147","article-title":"Zodasiran, an RNAi therapeutic targeting ANGPTL3, for mixed hyperlipidemia","volume":"391","author":"Rosenson","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2026.124333_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121656","article-title":"An injectable mitochondria-targeted nanodrug loaded-hydrogel for restoring mitochondrial function and hierarchically attenuating oxidative stress to reduce myocardial ischemia-reperfusion injury","volume":"287","author":"Zhang","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124333_bib27","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJMoa2211023","article-title":"OCEAN(a)-DOSE trial investigators, small interfering RNA to reduce lipoprotein(a) in cardiovascular disease","volume":"387","author":"O'Donoghue","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2026.124333_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc9450","article-title":"CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy","volume":"6","author":"Rosenblum","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2026.124333_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102486","article-title":"In vivo base editing of Angptl3 via lipid nanoparticles to treat cardiovascular disease","volume":"36","author":"Khirallah","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.biomaterials.2026.124333_bib30","doi-asserted-by":"crossref","first-page":"9729","DOI":"10.1038\/s41467-024-54108-1","article-title":"Base-editing corrects metabolic abnormalities in a humanized mouse model for glycogen storage disease type-Ia","volume":"15","author":"Arnaoutova","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124333_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41551-019-0501-5","article-title":"Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses","volume":"4","author":"Levy","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biomaterials.2026.124333_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202011068","article-title":"mRNA\u2010loaded lipid\u2010like nanoparticles for liver base editing via the optimization of central composite design","volume":"31","author":"Zheng","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2026.124333_bib33","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/s41563-025-02240-8","article-title":"Poly(carboxybetaine) lipids enhance mRNA therapeutics efficacy and reduce their immunogenicity","volume":"24","author":"Luozhong","year":"2025","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biomaterials.2026.124333_bib34","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1021\/acs.biomac.2c00137","article-title":"Poly(beta-amino ester)-based nanoparticles enable nonviral delivery of base editors for targeted tumor gene editing","volume":"23","author":"Chen","year":"2022","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2026.124333_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.102097","article-title":"Effective prevention of atherosclerosis by non-viral delivery of CRISPR\/Cas9","volume":"54","author":"Xu","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.biomaterials.2026.124333_bib36","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1038\/s41467-020-16439-7","article-title":"Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines","volume":"11","author":"Gao","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124333_bib37","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehae325","article-title":"Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy","volume":"45","author":"Gaudet","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biomaterials.2026.124333_bib38","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1038\/s41591-023-02494-2","article-title":"RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts","volume":"29","author":"Watts","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2026.124333_bib39","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1177\/2047487317717346","article-title":"Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: the role of PCSK9 inhibitors","volume":"24","author":"Pecin","year":"2017","journal-title":"Eur. J. Prev. Cardiol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226003571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226003571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T21:18:53Z","timestamp":1785359933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226003571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":39,"alternative-id":["S0142961226003571"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124333","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-functional poly(disulfide) enables \u201cOnce-and-for-all\u201d atherosclerosis therapy via precision hepatocyte base editing","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124333"}}